Please login to the form below

Not currently logged in
Email:
Password:

tezepelumab

This page shows the latest tezepelumab news and features for those working in and with pharma, biotech and healthcare.

GSK’s Nucala gets boost with self-administration approval

GSK’s Nucala gets boost with self-administration approval

Another challenger is AZ and Amgen’s  tezepelumab, which was awarded a breakthrough designation from the FDA for severe asthma last year.

Latest news

  • FDA rejects GSK’s Nucala for COPD FDA rejects GSK’s Nucala for COPD

    Another potentially strong challenge could come from AZ and Amgen’s tezepelumab, which has just been awarded a breakthrough designation from the FDA for severe asthma.

  • AZ, Amgen’s first-in-class asthma drug gets breakthrough status AZ, Amgen’s first-in-class asthma drug gets breakthrough status

    AstraZeneca and partner Amgen have picked up a breakthrough designation from the FDA for tezepelumab, a drug that AZ claims could be a “best in disease” therapy for severe asthma. ... medical officer.  The BTD “will help us bring tezepelumab to

  • AZ’s Fasenra hit by COPD trial failure AZ’s Fasenra hit by COPD trial failure

    IL-13 inhibitor tralokinumab has been abandoned after three failed late-stage trials, however, while AZ also has an Amgen-partnered thymic stromal lymphopoietin (TSLP) targeting antibody - tezepelumab - in phase III

  • AZ gets EMA green light for severe asthma drug Fasenra AZ gets EMA green light for severe asthma drug Fasenra

    Prospects for IL-13 inhibitor tralokinumab look terminal after three failed late-stage trials, however, and AZ also has an Amgen-partnered thymic stromal lymphopoietin (TSLP) targeting antibody - tezepelumab - in phase

  • AZ prices severe asthma drug Fasenra below competition AZ prices severe asthma drug Fasenra below competition

    AZ also has an Amgen-partnered thymic stromal lymphopoietin (TSLP) targeting antibody - tezepelumab - in phase III testing for severe asthma after reporting strong phase II data in uncontrolled patients earlier this

More from news
Approximately 1 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency comprising specialists with some of the best skills,...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics